Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.

[1]  J. S. Kim,et al.  Prospective evaluation of the clinical utility of interferon‐&ggr; assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease , 2011, Inflammatory bowel diseases.

[2]  C. Bowlus,et al.  The geoepidemiology of autoimmune intestinal diseases. , 2010, Autoimmunity reviews.

[3]  G. Gherardi,et al.  Experience with two cases of intestinal tuberculosis: utility of the QuantiFERON-TB Gold test for diagnosis. , 2008, Surgical infections.

[4]  G. Rook,et al.  In situ PCR for Mycobacterium tuberculosis in endoscopic mucosal biopsy specimens of intestinal tuberculosis and Crohn disease. , 2008, American journal of clinical pathology.

[5]  D. Amarapurkar,et al.  Diagnosis of Crohn's disease in India where tuberculosis is widely prevalent. , 2008, World journal of gastroenterology.

[6]  S. Edwards,et al.  Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. , 2007, Gastroenterology.

[7]  U. Ghoshal,et al.  Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn's disease and intestinal tuberculosis in India. , 2007, Journal of postgraduate medicine.

[8]  J. H. Kim,et al.  Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[9]  D. Epstein,et al.  Review article: the diagnosis and management of Crohn’s disease in populations with high‐risk rates for tuberculosis , 2007, Alimentary pharmacology & therapeutics.

[10]  M. Pentecost,et al.  Role of colonoscopic biopsy in distinguishing between Crohn’s disease and intestinal tuberculosis , 2006, Journal of Clinical Pathology.

[11]  K-J Kim,et al.  Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. , 2006, Endoscopy.

[12]  C. Dye.  Global epidemiology of tuberculosis , 2006, The Lancet.

[13]  X. Bossuyt.  Serologic markers in inflammatory bowel disease. , 2006, Clinical chemistry.

[14]  P. Rutgeerts,et al.  Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability. , 2005, Inflammatory bowel diseases.

[15]  R. Balicer,et al.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.

[16]  L. Jeyaseelan,et al.  Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease , 2005, Journal of gastroenterology and hepatology.

[17]  A. Duhamel,et al.  Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease , 2005, Gut.

[18]  M. Wong,et al.  Tuberculosis at Chris Hani Baragwanath Hospital: numbers of patients diagnosed and outcomes of referrals to district clinics. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  H. Drummond,et al.  Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations , 2004, Clinical and experimental immunology.

[20]  W. Reinisch,et al.  Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? , 2003, European journal of gastroenterology & hepatology.

[21]  Ji Won Kim,et al.  [Clinical features and therapeutic responses of perianal lesions in Crohn's disease]. , 2003, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[22]  D. Chang,et al.  Epidemiology of inflammatory bowel disease in the Songpa‐Kangdong district, Seoul, Korea, 1986–2005: A KASID study , 2003, Inflammatory bowel diseases.

[23]  R. Long,et al.  Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. , 2003, The Lancet. Infectious diseases.

[24]  J. S. Kim,et al.  Diagnostic Role of Anti-Saccharomyces cerevisiae Mannan Antibodies Combined With Antineutrophil Cytoplasmic Antibodies in Patients With Inflammatory Bowel Disease , 2002, Diseases of the colon and rectum.

[25]  Suk-Kyun Yang.  Current Status and Clinical Characteristics of Inflammatory Bowel Disease in Korea , 2002 .

[26]  P. Rutgeerts,et al.  Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. , 2001, Gastroenterology.

[27]  P. Rutgeerts,et al.  Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[28]  T. Matsui,et al.  Crohn's disease in Japan , 2000, Diseases of the colon and rectum.

[29]  S. Targan,et al.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics , 2000, Gut.

[30]  M. Mathan,et al.  Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn’s disease from tuberculosis , 1999, Gut.

[31]  S. Targan,et al.  Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. , 1998, Gastroenterology.

[32]  S. Targan,et al.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.

[33]  P. Jacquinot,et al.  Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.

[34]  S. Chari,et al.  Does Crohn's disease need differentiation from tuberculosis? , 1996, Journal of gastroenterology and hepatology.

[35]  S. Allan,et al.  Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae. , 1991, Immunology letters.

[36]  J. Main,et al.  Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. , 1990, Gut.

[37]  M. Kerr,et al.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.

[38]  Rajiva Gupta,et al.  Anti-Saccharomyces cerevisiae Antibody Does Not Differentiate Between Crohn's Disease and Intestinal Tuberculosis , 2006, Digestive Diseases and Sciences.

[39]  G. Lee,et al.  [Clinical characteristics at diagnosis and course of Korean patients with Crohn's disease]. , 2004, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.